tradingkey.logo

Unitedhealth Group Inc

UNH
View Detailed Chart
292.290USD
-1.730-0.59%
Close 01/29, 16:00ETQuotes delayed by 15 min
264.77BMarket Cap
22.09P/E TTM

Unitedhealth Group Inc

292.290
-1.730-0.59%
Intraday
1m
30m
1h
D
W
M
D

Today

-0.59%

5 Days

-17.54%

1 Month

-11.14%

6 Months

+11.96%

Year to Date

-11.46%

1 Year

-45.68%

View Detailed Chart

Key Insights

Unitedhealth Group Inc's fundamentals are relatively healthy, with industry-average ESG disclosure.and its growth potential is significant.Its valuation is considered fairly valued, ranking 61 out of 76 in the Healthcare Providers & Services industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 398.27.In the medium term, the stock price is expected to trend down.Despite a weak stock market performance over the past month, the company shows strong technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Unitedhealth Group Inc's Score

Industry at a Glance

Industry Ranking
61 / 76
Overall Ranking
305 / 4540
Industry
Healthcare Providers & Services

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Media Coverage

Last 24 hours
Coverage Level

47°C

Very Low
Very High
Neutral

Unitedhealth Group Inc Highlights

StrengthsRisks

UnitedHealth Group Incorporated is an American multinational for-profit organization that specializes in health insurance and healthcare services, located in Eden Prairie, Minnesota. Operating under the UnitedHealthcare brand for insurance products and the Optum brand for healthcare services, it is recognized as the world's seventh-largest company by revenue and the largest healthcare corporation by revenue. The company ranks 8th on the 2024 Fortune Global 500 list, with a market capitalization of $460.3 billion as of December 20, 2024. UnitedHealth Group has encountered numerous investigations, lawsuits, and penalties—including SEC enforcement related to stock option backdating, Medicare overbilling, unfair claims practices, denials of mental health treatments, and anticompetitive conduct—illuminating deep-rooted issues of fraud, patient harm, and corporate misconduct.

Industry Leader
The company's revenue leads the industry, with the latest annual revenue totaling USD 447.57B.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 20.53% year-on-year.
High Dividend
The company is a high dividend payer, with the latest dividend payout ratio of 52.29%.
Stable Dividend
The company has regularly paid dividends over the past 5 years, with the latest dividend payout ratio of 52.29%.
Fairly Valued
The company’s latest PE is 22.22, at a medium 3-year percentile range.
Institutional Selling
The latest institutional holdings are 756.40M shares, decreasing 5.79% quarter-over-quarter.
Held by Jerome Dodson | PARNX
Star Investor Jerome Dodson | PARNX holds 208.92K shares of this stock.
Higher Market Activity
The company has more investor interest, with a 20-day turnover ratio of 1.68.

Analyst Rating

Based on 30 analysts
Buy
Current Rating
398.267
Target Price
+11.79%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Unitedhealth Group Inc News

UNH Stock Analysis: UnitedHealth (UNH) Down 50% in 2025 — Buffett Still Holds 45 Million Shares. Time to Buy the Dip?

UnitedHealth Group Stock Analysis: Why has UNH's stock price halved this year? Should investors follow Buffett's lead and continue holding? Will UNH's stock price hit new lows?

TradingKeyFri, Nov 28
UnitedHealth Group Stock Analysis: Why has UNH's stock price halved this year? Should investors follow Buffett's lead and continue holding? Will UNH's stock price hit new lows?

US 13F Filings Flood In: 'Smart Money' Shifts Could Deepen Equity Correction

TradingKey - As US tech stocks grapple with AI bubble concerns and faltering performance, quarterly 13F filings from investment institutions are entering a heavy disclosure period. These reports will unveil "smart money" strategies and could influence future market direction. However, given recent

TradingKeyThu, Nov 13
TradingKey - As US tech stocks grapple with AI bubble concerns and faltering performance, quarterly 13F filings from investment institutions are entering a heavy disclosure period. These reports will unveil "smart money" strategies and could influence future market direction. However, given recent

As Rotation from Tech to Value Gains Steam, Is It Time to Buy the Dow Jones by End-2025?

TradingKey - The Dow Jones Industrial Average has reached successive record highs, and its outperformance against the Nasdaq over the past two days reached the highest level in nine months, signaling an early market style shift from tech to blue-chip or value stocks amid persistent concerns about

TradingKeyThu, Nov 13
TradingKey - The Dow Jones Industrial Average has reached successive record highs, and its outperformance against the Nasdaq over the past two days reached the highest level in nine months, signaling an early market style shift from tech to blue-chip or value stocks amid persistent concerns about

Why UnitedHealth Stock Dipped Today After Bumping Higher Monday

Key PointsOne pundit tracking the stock became less bullish on its future.He knocked down his price target by 37%.10 stocks we like better than UnitedHealth Group › What the stock analysis community giveth, it can also taketh away.That was the dynamic behind the slide of UnitedHealth Group...

OtherWed, Aug 20
Key PointsOne pundit tracking the stock became less bullish on its future.He knocked down his price target by 37%.10 stocks we like better than UnitedHealth Group › What the stock analysis community giveth, it can also taketh away.That was the dynamic behind the slide of UnitedHealth Group...

Warren Buffett Q2 2025 13F Analysis: Betting on UnitedHealth Again After 14 Years

TradingKey - In Q2 2025, the value of Berkshire Hathaway’s investment portfolio declined from $259.8 billion in Q1 to $257.5 billion, a decrease of 0.89%. Analysis indicates that this drop is primarily driven by a net capital outflow of 0.78%. The outflow may be linked to changing market conditions

TradingKeyFri, Aug 15
TradingKey - In Q2 2025, the value of Berkshire Hathaway’s investment portfolio declined from $259.8 billion in Q1 to $257.5 billion, a decrease of 0.89%. Analysis indicates that this drop is primarily driven by a net capital outflow of 0.78%. The outflow may be linked to changing market conditions

After Plummeting 40%, Where Will UnitedHealth Group Stock Be in 1 Year? Here Is What History Suggests.

UnitedHealth Group (NYSE: UNH) has been one of the more interesting case studies in the stock market this year. Many stocks that have witnessed plummeting share prices can point to President Donald Trump's new tariff policies as the culprit.

The Motley FoolWed, Jun 18
UnitedHealth Group (NYSE: UNH) has been one of the more interesting case studies in the stock market this year. Many stocks that have witnessed plummeting share prices can point to President Donald Trump's new tariff policies as the culprit.

Financial Indicators

EPS

Relevant data have not been disclosed by the company yet.

Total revenue

Relevant data have not been disclosed by the company yet.

Unitedhealth Group Inc Info

UnitedHealth Group Incorporated is an American multinational for-profit organization that specializes in health insurance and healthcare services, located in Eden Prairie, Minnesota. Operating under the UnitedHealthcare brand for insurance products and the Optum brand for healthcare services, it is recognized as the world's seventh-largest company by revenue and the largest healthcare corporation by revenue. The company ranks 8th on the 2024 Fortune Global 500 list, with a market capitalization of $460.3 billion as of December 20, 2024. UnitedHealth Group has encountered numerous investigations, lawsuits, and penalties—including SEC enforcement related to stock option backdating, Medicare overbilling, unfair claims practices, denials of mental health treatments, and anticompetitive conduct—illuminating deep-rooted issues of fraud, patient harm, and corporate misconduct.

Ticker SymbolUNH
CompanyUnitedhealth Group Inc
CEONoel (Timothy John)
Websitehttps://www.unitedhealthgroup.com/
KeyAI